Acne Therapeutics Market Size, Share, Growth, Trends with Impact of Covid-19 and Forecast by 2022-2030
SKU ID : INH-18092790 | Publishing Date : 26-Apr-2021 | No. of pages : 100
Acne Therapeutics Market Report is projected to grow at a CAGR of XX% during the forecast period 2021-2024.
Company Coverage: -
- Cipher Pharmaceuticals
- Glaxosmithkline PLC
- Bayer AG
- Teva Pharmaceuticals
- Ranbaxy
- Allergan
- F. Hoffmann-la Roche Ltd
- Nestle SA (Galderma)
- Johnson & Johnson
- Valeant Pharmaceuticals International Inc.
Scope: -
As per the , acne is a chronic inflammatory skin disease commonly affecting the adolescent and adult populations. Abnormal hormone production is found to be the key causative factor. The increasing use of acne medications is being indicated for its treatment. These include several prescriptions and over-the-counter medicines, such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives, among others. However, the development of effective therapeutics, with lesser side effects and high potential in untapped markets, is expected to provide growth opportunities to the overall market.
Regions: -
- North America
- Asia-Pacific
- Europe
- South America
- Africa
Key Highlights of Report:
- Provides market definition and overview by studying objectives like market scope and market size estimation.
- Provides research methods and logic based on historic data.
- Analysis market competition, market performance worldwide, manufactures basic information, Sales, Value, Price and Gross Margin.
- Analysis on segmentation of types, applications and regions based on historical Data and market forecasts.
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region